JAMA Network
About The Study: Researchers assessed coverage for buprenorphine, a medication used to treat opioid use disorder, and prior authorization requirements in U.S. commercial formulary data from 2017 to 2021.
Authors: Thuy D. Nguyen, Ph.D., of the University of Michigan in Ann Arbor, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamahealthforum.2022.1821)
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
